Emerging therapeutic research for glioblastoma and ovarian cancer

New experimental treatments are under investigation for glioblastoma and ovarian cancer, both characterized by high mortality and limited standard-of-care options. The clinical efficacy and scalability of these interventions remain unproven, as the report lacks specific data on trial phases or patient outcomes.